ヘルスケア向けサードパーティ・ロジスティクス（3PL）市場規模、成長と動向分析レポート 2026-2033年

世界のヘルスケア向けサードパーティ・ロジスティクス（3PL）市場の規模は、2025年に2,798億米ドルと評価され、2026年から2033年にかけて年平均成長率（CAGR）8.2%で推移し、2026年の3,003億米ドルから2033年には5,221億米ドルに達するとGrand View Researchでは予測しています。2025年時点では、北米のヘルスケア向け3PL市場が世界市場の39.4%を占め、最大のシェアを記録しました。ヘルスケア向け3PLサービスへの需要は、ヘルスケア製品のニーズ拡大、技術の進歩、厳格な規制への対応といった要因によって促進されています。

市場の主な動向とインサイト

• 業界別：2025年、バイオ医薬品セグメントが59.2%の最大市場シェアを占めました。
• サービス別：2025年、倉庫・保管セグメントが最大の市場シェアを占めました。
• サプライチェーン別：2025年、非コールドチェーン物流セグメントが最大のシェアを占めました。

地域別のハイライト

• 最大の地域市場：北米（2025年時点で収益シェア39.4%）
• 最も急成長している地域市場：アジア太平洋地域（2026年～2033年の期間で最高のCAGRを記録）
• 米国のヘルスケア向けサードパーティ・ロジスティクス（3PL）市場は、予測期間中に大幅な成長が見込まれています。

ヘルスケア企業がグローバルに事業を拡大する中、リソースを効率的に管理し、諸経費を最小限に抑えるために、3PL（サード・パーティ・ロジスティクス）プロバイダーへの依存度が高まっています。さらに、DHLグループとVizient社との提携のようなパートナーシップは、業界の課題に対処しつつ、提供サービスの拡充を可能にしています。ヘルスケア関連の製造業者、流通業者、医療提供者は、業務の効率化と経費削減を図る上で、専門的な物流パートナーの力を活用しています。

物流業務を3PLプロバイダーに委託することで、企業は高度なサプライチェーン技術の活用や配送ネットワークの最適化が可能になるほか、温度管理が必要な医薬品、医療機器、バイオ医薬品の取り扱いに関する専門的なノウハウを享受できます。これにより、大規模な社内インフラ投資の必要性が減り、人件費の抑制や在庫管理精度の向上が実現します。加えて、3PLパートナーは、戦略的なルート計画や配送業者との連携を通じて、貨物の集約、ラストワンマイル配送の効率化、輸送コストの削減を行うことができます。厳格な規制遵守が求められる市場において、3PLプロバイダーは、適切な文書作成、ラベル表示、保管体制を確保することで、多大なコストを招くミスや遅延の防止にも貢献します。こうした業務の最適化とコスト削減という相乗効果により、病院、診療所、薬局、ヘルスケア製品メーカーの間で、3PLサービスの導入がさらに拡大しています。

サプライチェーンに関する考察

サプライチェーンの区分において、2025年には非コールドチェーン物流セグメントが最大のシェアを占めました。これは、温度管理を必要としない医薬品の効率的な流通に対する需要が高まっていることが主な要因です。さらに、ジェネリック医薬品、一般用医薬品（OTC）、医療用品への需要拡大に加え、医療インフラや調剤薬局ネットワークの拡充に伴い、より高度な物流ソリューションへのニーズが高まっていることも市場成長を後押ししています。加えて、製薬企業はコストの最適化、サプライチェーンの柔軟性向上、業務効率化を図るため、非コールドチェーン物流業務を専門の3PL（サード・パーティ・ロジスティクス）事業者へ委託する動きを強めています。さらに、医療品流通におけるEコマース・プラットフォームの普及拡大により、非コールドチェーン物流に適した、信頼性の高いラストワンマイル配送ソリューションへの需要も加速しています。

一方、コールドチェーン物流セグメントは、医薬品、バイオ医薬品、個別化医療、ワクチン、再生医療といった分野における、温度管理を要する製品への需要拡大によって牽引されています。また、世界的に複雑な構造を持つバイオ医薬品、遺伝子治療、細胞治療の利用が増加していることから、厳格な温度管理や極低温での保管・輸送を伴うコールドチェーン物流サービスへのニーズが高まっています。さらに、医薬品やバイオ医薬品においては、保管および輸送中の化学的安定性や製品の有効性、無菌性の維持が極めて重要であり、こうした特性も市場の成長をさらに後押ししています。

本レポートでは、世界、地域、国別の収益成長を予測するとともに、2021年から2033年にかけての各サブセグメントにおける最新の業界動向を分析しています。本調査において、Grand View Researchは世界のヘルスケア向けサードパーティ・ロジスティクス（3PL）市場を、業界、サービス、サプライチェーン、および地域に基づいて区分しています。

Healthcare Third-Party Logistics Market Summary

The global healthcare third-party logistics market size was valued at USD 279.8 billion in 2025 and is projected to grow from USD 300.3 billion in 2026 to USD 522.1 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America healthcare third-party logistics market held the largest share of 39.4% of the global market in 2025. The demand for healthcare third-party logistics (3PL) services is driven by factors such as the growing need for healthcare products, technological advancements, and stringent regulatory compliance.

As healthcare companies expand globally, they increasingly depend on 3PL providers to manage resources efficiently and minimize overhead costs. In addition, collaborative partnerships, such as DHL Group’s agreement with Vizient Inc., further enhance service offerings while addressing industry challenges. Healthcare manufacturers, distributors, and providers rely on specialized logistics partners to streamline operations and minimize expenses.

Outsourcing logistics to 3PL providers enables companies to leverage advanced supply chain technologies, optimize distribution networks, and specialize expertise in handling temperature-sensitive pharmaceuticals, medical devices, and biologics. This reduces the need for heavy in-house infrastructure investments, lowers labor costs, and improves inventory management accuracy. Moreover, 3PL partners can consolidate shipments, improve last-mile delivery efficiency, and reduce transportation costs through strategic route planning and carrier partnerships. In a market where compliance with stringent regulatory requirements is essential, 3PL providers also help mitigate costly errors and delays by ensuring proper documentation, labeling, and storage. The combined impact of operational optimization and cost savings drives greater adoption of third-party logistics services across hospitals, clinics, pharmacies, and healthcare manufacturers.

Moreover, ongoing digital transformation in healthcare logistics has been redefining operational standards, with providers steadily integrating advanced tools to handle increasingly complex and regulated supply chains. Over the past three years, the sector has moved from basic tracking systems to fully connected, data-driven platforms capable of predicting risks before they occur. For instance, the UPS Healthcare expanded its cold chain network with AI-enabled monitoring, enabling predictive alerts for temperature-sensitive biologics and high-value vaccines. The following year, DHL Supply Chain introduced IoT-based sensor technology across its global healthcare facilities. This allows end-to-end visibility for products such as cell and gene therapies, where even minor environmental deviations can impact efficacy. By 2025, these capabilities will have matured into comprehensive, real-time control towers that monitor and dynamically adjust routes and storage conditions, giving providers a significant service advantage over traditional logistics models.

Furthermore, reverse logistics is a critical growth driver in the healthcare third-party logistics industry, particularly within the biopharmaceutical sector, where product recalls, returns, and recycling processes require specialized handling. The increasing complexity of cold chain products, including biologics, cell therapies, and vaccines, has heightened the need for robust reverse logistics systems that can recover, transport, and dispose of sensitive materials in compliance with stringent regulatory standards. Leading providers invest in purpose-built infrastructure and digital tracking tools to ensure that returned products maintain chain-of-custody integrity and that disposal processes meet environmental and safety regulations. For instance, DHL Supply Chain has expanded its healthcare-focused facilities to incorporate dedicated return processing zones equipped with temperature-controlled inspection areas, enabling rapid assessment and safe reallocation or destruction of returned biopharmaceutical products. Similarly, Marken has strengthened its clinical trial logistics network to manage returns of unused investigational products from decentralized trial sites, using secure, GDP-compliant transport to prevent contamination risks.

Market Dynamics

Drivers: Rising Demand for Cold Chain Logistics

The industry is experiencing a significant surge in demand for cold chain logistics, driven primarily by the rapid growth of temperature-sensitive biopharmaceuticals, vaccines, and advanced therapies. The proliferation of biologics, cell and gene therapies, and mRNA-based vaccines has created an urgent need for sophisticated cold chain infrastructure to maintain strict temperature controls throughout the supply chain. Industry leaders have responded by expanding specialized facilities and investing in next-generation refrigeration and monitoring technologies. For instance, DHL Supply Chain has recently launched multiple ultra-low temperature storage hubs across North America and Europe, specifically designed to support the storage and distribution of emerging therapies requiring temperatures as low as -80°C.

Similarly, UPS Healthcare has upgraded its temperature-controlled fleet and packaging solutions to cater to the growing volume of sensitive shipments globally. These investments ensure product integrity and regulatory compliance, critical factors that underpin successful treatment outcomes and patient safety. Furthermore, the ongoing expansion of global immunization programs and emergency response initiatives has intensified the need for robust cold chain logistics networks. For instance, in April 2026, Geodis launched its first healthcare-focused cold chain cross-dock facility in the Americas to support the handling of temperature-sensitive pharmaceuticals and medical products. Located in Chicago, the 78,000-square-foot bonded Container Freight Station (CFS) includes a dedicated 5,200-square-foot temperature-controlled area. Integrated into Geodis’ freight forwarding network, the site is designed specifically for healthcare logistics, offering short-term storage and specialized management for pharmaceutical import and export shipments transported by air and sea.

Restraints: Rising Operational Costs and Labor Shortages

The healthcare 3PL industry faces growing restraints due to escalating operational costs and persistent labor shortages that challenge service scalability and profitability. Increasing fuel prices, inflation-driven rises in warehouse rental rates, and the need for investments in advanced cold chain technologies have collectively pushed up the cost base for logistics providers. For instance, several global 3PL firms reported sharp increases in last-mile delivery expenses, particularly in regions with complex regulatory environments or underdeveloped infrastructure. These cost pressures often force providers to balance competitive pricing and invest in critical capabilities such as temperature-controlled storage and advanced tracking systems. In addition, labor shortages, especially in skilled roles such as cold chain specialists, compliance officers, and IT technicians, have constrained operational capacity. The workforce challenges have led to higher turnover rates and increased wage demands, further squeezing margins. These factors increase operational risks and costs, restricting market penetration in regions with high growth potential. Rising operational expenses and labor shortages represent significant drives the healthcare 3PL providers, which support to strategically manage profitability and competitive positioning.

Market Concentration & Characteristics

The industry growth stage is moderate, and growth is accelerating. The market is characterized by the degree of innovation, level of M&A activities, regulatory impact, service expansion, and regional expansion.

Innovation is driven by advancements in cold chain logistics, real-time tracking, and automation. The integration of IoT, AI-driven route optimization, and blockchain for shipment verification has enhanced supply chain transparency.

The industry has witnessed high levels of mergers and acquisitions, as logistics providers seek to expand service capabilities and geographic reach. Major players such as UPS Healthcare, FedEx, and DHL Supply Chain have acquired specialized cold chain and clinical trial logistics firms to strengthen their presence in niche markets.

Regulatory compliance plays a defining role in shaping the healthcare 3PL industry. Strict guidelines such as Good Distribution Practices (GDP), Good Manufacturing Practices (GMP), FDA requirements, and EU pharmaceutical logistics standards drive investments in validated storage, temperature monitoring, and serialization technologies. Compliance with evolving drug traceability laws, such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD), adds complexity to logistics operations.

Leading healthcare 3PL providers are expanding their service offerings to include clinical trial logistics, specialty drug distribution, and home healthcare delivery. The rise of direct-to-patient (DTP) models and decentralized clinical trials has pushed logistics providers to develop last-mile solutions, temperature-controlled packaging, and patient-centric delivery systems.

Healthcare 3PL providers are aggressively expanding in Asia-Pacific, Latin America, and the Middle East to support the growing pharmaceutical markets in these regions. Investments in cold chain infrastructure, regional distribution hubs, and regulatory expertise are helping global logistics firms strengthen their foothold in emerging markets. The increasing outsourcing of pharmaceutical manufacturing to India and China is also driving demand for specialized logistics solutions in these regions.

Opportunity Analysis

The industry presents significant growth opportunities due to the rising demand for pharmaceuticals, biologics, vaccines, and medical devices worldwide. Increasing healthcare expenditure, aging populations, and the growing prevalence of chronic diseases are driving the need for efficient and temperature-controlled healthcare supply chains. The rapid expansion of biologics and personalized medicines has further increased demand for specialized cold chain logistics, creating opportunities for 3PL providers to invest in advanced refrigerated transportation and warehousing infrastructure. In addition, pharmaceutical companies are increasingly outsourcing logistics operations to reduce operational costs, improve supply chain efficiency, and focus on core competencies such as drug development and manufacturing. The growth of e-commerce and direct-to-patient delivery models is also accelerating demand for last-mile healthcare logistics services. Emerging markets such as India, China, Brazil, and Southeast Asian countries offer strong expansion potential due to improving healthcare infrastructure and rising pharmaceutical production activities.

Technological advancements, including IoT-enabled tracking, AI-driven route optimization, blockchain-based traceability, and automated warehousing systems, are further enhancing operational efficiency and regulatory compliance. Moreover, increasing regulatory requirements for safe pharmaceutical transportation are encouraging healthcare companies to partner with specialized and compliant third-party logistics providers globally.

Impact of U.S. Tariffs on the Global Healthcare Third-Party Logistics Market

U.S. tariffs on pharmaceutical ingredients, medical devices, and healthcare-related imports are significantly influencing the industry. Rising trade tensions and tariff uncertainties have encouraged pharmaceutical and medical device manufacturers to diversify sourcing and manufacturing operations beyond China toward countries such as India, Vietnam, and Mexico. This geographic shift has increased demand for healthcare 3PL providers capable of managing complex multi-country transportation, customs clearance, and regulatory compliance processes.

In addition, companies are increasing regional warehousing and inventory buffering strategies to reduce supply chain disruptions caused by tariffs and fluctuating trade policies. As a result, healthcare logistics providers are expanding temperature-controlled storage facilities and distribution networks to support the uninterrupted delivery of pharmaceuticals, vaccines, and biologics. Tariff-related supply chain restructuring has also accelerated investment in regional logistics hubs and localized distribution centers, creating new business opportunities for healthcare 3PL companies.  Furthermore, changing import regulations have increased the need for specialized compliance management, serialization tracking, and customs brokerage services. Thus, U.S. tariffs are reshaping global healthcare supply chains and driving greater reliance on advanced, flexible, and regulatory-compliant third-party logistics solutions across international healthcare markets.

Technological Advancements

Technological advancements are significantly transforming the industry by improving supply chain visibility, operational efficiency, and regulatory compliance. Healthcare 3PL providers are increasingly adopting IoT-enabled monitoring systems that provide real-time tracking of temperature-sensitive pharmaceutical shipments, helping maintain product integrity during transportation and storage. Artificial intelligence and predictive analytics are further enhancing logistics performance by optimizing delivery routes, forecasting demand fluctuations, and minimizing supply chain disruptions. In addition, blockchain technology is improving transparency and traceability across healthcare supply chains by enabling secure documentation and reducing the risk of counterfeit pharmaceuticals.

Warehouse automation and robotics are streamlining order fulfillment processes, increasing inventory accuracy, and reducing labor dependency in pharmaceutical distribution centers. Cloud-based transportation management systems are also enabling centralized control over inventory, warehousing, and transportation operations while improving coordination among manufacturers, distributors, and healthcare providers. These digital innovations are becoming increasingly important as healthcare supply chains grow more complex due to rising biologics demand, global pharmaceutical trade expansion, and stricter regulatory requirements. As a result, technological integration is strengthening the ability of healthcare third-party logistics providers to deliver safe, efficient, and compliant supply chain solutions worldwide.

Pricing Model Analysis

The industry employs various pricing models tailored to service complexity and customer needs. The cost-plus pricing model is prevalent in long-term contracts for pharmaceuticals and medical devices. Providers calculate operational expenses like warehousing, transportation, compliance, and packaging and add a fixed profit margin. This model offers pricing transparency but may not encourage optimization of costs.

The fixed-rate model involves a set fee for distinct logistics services over a specified period, making it ideal for consistent healthcare deliveries and providing clients with cost predictability. Activity-based pricing is often used in complex logistics scenarios, where clients pay separately for services such as cold chain storage, order picking, customs clearance, and temperature monitoring. This model enhances flexibility and cost efficiency for variable shipment needs. Moreover, performance-based pricing ties a portion of the 3PL provider’s revenue to service quality metrics, like on-time delivery, temperature compliance, and shipment accuracy. This approach drives accountability and promotes high standards in critical transportation for pharmaceuticals and biologics.

Industry Insights

On the basis of industry, the biopharmaceuticals segment held the largest market share of 59.2% in 2025. The growth is driven by increasing complexity of global supply chains, growing biopharmaceutical manufacturing, and a rising demand for efficient, compliant, and temperature-controlled distribution networks. Besides, increased focus on personalized medicines, biosimilars, and advanced biologics has led to an increased need for specialty logistics capabilities, which is expected to drive the market growth. In addition, changing regulatory frameworks in markets have increased the need for operational precision, traceability, and quality assurance, further fueling the 3PL providers. Furthermore, the globalization of clinical trials and commercial supply networks has fueled the requirement for logistic partners. Such factors are expected to drive the market over the estimated time period.

The pharmaceutical segment is driven by the globalization of pharmaceutical manufacturing, rising demand for cost-effective distribution models, and the necessity to comply with stringent regulations. Besides, increased drug consumption, the expansion of generics, and an increased focus on timely delivery are expected to drive the 3PL services in the pharmaceutical industry. Moreover, several companies increasingly focus on outsourcing logistics services to optimize efficiency, lower overhead costs, and ensure consistent service quality across various regions. In addition, evolving trade policies and intricate cross-border supply chains have increased the need for specialized logistics providers who can efficiently manage regulatory documentation, customs clearance, and distribution. For instance, the Global Pharma Logistics Summit in Mumbai demonstrates the necessity for 3PLs as key enablers of resilient pharmaceutical supply chains. Emerging themes included the importance of tracking and tracing, particularly for temperature-sensitive products such as biologics.

Service Insights

On the basis of service, the warehousing and storage segment held the largest market share in 2025, driven by growing demand for temperature-controlled storage, regulatory compliance, and inventory management solutions. The increasing production of biologics, specialty drugs, and medical devices has led to higher investments in GMP-compliant and GDP-certified warehouses. In addition, the expansion of regional distribution hubs, automation in storage facilities, and just-in-time inventory models further strengthened the segment growth. With pharmaceutical and medtech companies outsourcing logistics to focus on core R&D and manufacturing, warehousing remains a critical component of the healthcare supply chain. Moreover, rapid growth in biologics, personalized therapies, and clinical trial supplies that require validated, temperature-controlled environments is contributing to segment growth. Besides, inventory complexity has increased with SKU proliferation and multi-channel distribution, prompting the usage of specialized storage solutions, segmented racking, and controlled access.

The transportation segment is driven by the increasing demand for home healthcare and requires reliable transportation for healthcare professionals, medical equipment, and supplies. According to WHO projections, 80% of older individuals will reside in low- and middle-income countries by 2050, prompting urgent challenges for health and social systems, particularly in enhancing access to non-emergency medical transport (NEMT) amid the rapid aging population. Moreover, increasing demand for efficient and specialized logistics solutions across biopharmaceutical supply chains is accelerating the segment growth. The growing focus on maintaining the integrity and timely delivery of high-value products, from temperature-sensitive biologics to high-demand generics, supports the market growth. Moreover, the growing demand for thorough tracking capabilities to ensure adherence to strict regulatory standards, especially in handling controlled substances and biologics, is expected to drive segment growth.

Supply Chain Insights

On the basis of supply chain, the non-cold chain logistics segment accounted for the largest share in 2025, driven by the increasing demand for efficient pharmaceutical product distribution that does not require temperature-controlled environments. Besides, other factors contributing to market growth are rising demand for generic drugs, over-the-counter (OTC) medications, and medical supplies, combined with expanding healthcare infrastructures and retail pharmacy networks, which have increased the need for enhanced logistics solutions. Moreover, pharmaceutical companies increasingly outsource non-cold chain logistics operations to specialized 3PL providers to optimize costs, improve supply chain flexibility, and enhance operational efficiency. In addition, the rising adoption of e-commerce platforms in healthcare distribution has accelerated demand for reliable last-mile delivery solutions tailored to non-cold chain logistics.

The cold chain logistics segment is driven by increasing demand for temperature-sensitive products in pharmaceuticals, biopharmaceuticals, personalized medicine, vaccines, and regenerative therapies. Besides, increased use of complex biologics, gene therapies, and cell therapies across the globe has led to a rising need for cold chain logistics services with stringent temperature control and cryogenic storage. Moreover, in pharmaceutical and biopharmaceutical products, the chemical stability and product efficacy play a significant role in product sterility during storage and transportation, further supporting market growth.

Regional Insights  

North America healthcare third-party logistics market held the largest revenue share of 39.4% in 2025, attributed to the increasing complexity of pharmaceutical and biopharmaceutical supply chains, the rising number of temperature-sensitive products, and stringent regulatory requirements. Besides, some factors contributing to the market are the rising demand for specialized logistics services due to growing requirements for personalized medicine, biosimilars, and high-value biologics. This has led many pharmaceutical and medical device companies to outsource their non-core logistics functions to reliable 3PL providers.

U.S. Healthcare Third-Party Logistics Market Trends

The healthcare third-party logistics market in the U.S. accounted for the highest market share in North America, owing to the increasing complexity of pharmaceutical and medical supply chains, increased demand for temperature-controlled logistics, and the need to meet stringent regulatory standards. Besides, as the healthcare industry evolves, the advancements in biologics, specialty drugs, and personalized therapies are expected to drive the logistics outsourcing to enhance operational efficiency and manage costs effectively. This trend has been further fueled by the shift toward value-based patient-centric delivery models, leading to broader adoption of 3PL services nationwide.

Canada healthcare third-party logistics market is driven by the pharmaceutical and biotechnology sectors, a growing demand for cold chain logistics, and stringent regulatory compliance requirements. Besides, the increasing imports of high-value therapeutics, rising usage of biologics, and a shift toward outsourcing non-core functions have led manufacturers to partner with specialized 3PL providers, further supporting the market growth. Besides, the need for cost efficiency and country distribution coverage, particularly in remote and underserved areas, has led to a rising requirement for third-party logistics in supporting Canada’s healthcare market.

Europe Healthcare Third-Party Logistics Market Trends

The healthcare third-party logistics market in Europe is driven by the region’s expanding pharmaceutical and biologics manufacturing base, rising harmonization of regulations across the EU, and the increasing demand for cross-border distribution of healthcare products. Besides, the companies are increasingly outsourcing logistics functions, which helps reduce operational complexities while maintaining compliance with strict regulations for handling temperature-sensitive and high-value medical products. In addition, changing demographic scenarios, including an aging population and a rising prevalence of chronic diseases, combined with increased spending on specialty drugs, are expected to drive the need for efficient and scalable supply chain solutions managed by specialized 3PL providers.

Germany healthcare third-party logistics market held the highest share in 2025, fueled by its strong pharmaceutical manufacturing base, increased healthcare expenditure, and a robust regulatory framework that ensures product safety and quality. Besides, the rising demand for biologics, specialty drugs, and advanced medical devices has increased the need for reliable, compliant, and time-sensitive distribution solutions. In addition, the growth of e-pharmacies, an aging population, and an increasing prevalence of chronic diseases further emphasize the reliance on specialized logistics providers for the seamless movement of healthcare products throughout the supply chain.

The healthcare third-party logistics market in the UK is expected to grow significantly over the forecast period, driven by rising advanced pharmaceutical manufacturing capabilities, robust clinical research activities, and a growing demand for specialized medicines. Besides, the increasing prevalence of biologics, personalized treatments, and high-value medical devices has increased the need for secure, compliant, and efficient logistics solutions. In addition, a growing aging population, rising chronic diseases, and the expansion of e-pharmacies have further fueled the reliance on 3PL providers to oversee complex, time-sensitive, and regulated supply chains.

Asia Pacific Healthcare Third-Party Logistics Market Trends

The healthcare third-party logistics market in Asia Pacific is expected to grow at the fastest CAGR over the forecast period, driven by the rapid expansion of pharmaceutical manufacturing, increased international trade for generics and active pharmaceutical ingredients (APIs), and the ongoing development of the healthcare industry in emerging countries. Other factors contributing to market growth are lower service costs, adherence to evolving Good Distribution Practice (GDP) standards, improved access to medicines, rising requirements for e-commerce, increasing focus on regulatory compliance for logistics, and technological advancements.

China healthcare third-party logistics market is driven by a rapidly aging population, the increasing prevalence of chronic diseases, and a rising demand for advanced therapies and high-quality healthcare products. Besides, the expansion of pharmaceutical and biopharmaceutical manufacturing capabilities, along with strong government initiatives aimed at improving healthcare accessibility and efficiency, has led to a significant increase in the outsourcing of logistics operations.

The healthcare third-party logistics market in Japan is driven by a rising aging population, the growing demand for advanced medical treatments, and the expansion of its pharmaceutical and biopharmaceutical sectors. Besides, growing chronic diseases and lifestyle-related diseases have increased the usage of prescription drugs, medical devices, and diagnostic equipment, creating a need for reliable and compliant logistics networks. In addition, government policies aimed at improving healthcare access and the country’s emphasis on quality and precision in supply chain operations have fueled the market growth.

India healthcare third-party logistics market is experiencing rapid growth, driven by expanding pharmaceutical and biopharmaceutical markets, rising demand for specialty drugs, and increased export activities to regulated and emerging markets. Besides, the government initiatives, particularly the Production Linked Incentive (PLI) scheme for pharmaceuticals and medical devices, alongside improvements in healthcare infrastructure, are expected to drive the need for specialized logistics solutions. For instance, according to an article published by the Economic Times in March 2025, the launch of modernized healthcare logistics infrastructure in India aims to enhance supply chain efficiency for pharmaceuticals, medical devices, and cold chain logistics. This initiative supports timely delivery, reduces wastage, and strengthens distribution networks, contributing significantly to the country’s healthcare sector advancement.

Latin America Healthcare Third-Party Logistics Market Trends

The healthcare third-party logistics market in the Latin America region is expected to grow significantly, due to increasing demand for pharmaceuticals & biopharmaceuticals, along with the expansion of regional drug manufacturing. In addition, government initiatives aimed at improving access to essential medicines are expected to support market growth. Besides, regulatory reforms in major countries such as Brazil and Argentina have fueled a supportive environment for developing logistics infrastructure that complies with GDP standards.

Brazil’s healthcare third-party logistics market is experiencing robust growth, driven by rising demand for efficient and reliable supply chain solutions. Besides, the country’s vast geography and underdeveloped healthcare infrastructure pose significant logistical challenges, which drive the need for 3PL services among the healthcare providers. In addition, expanding healthcare access in rural and underserved areas further fuels the reliance on 3PL providers to enhance delivery efficiency and improve patient outcomes. Moreover, the key players are investing in temperature-controlled logistics, broadening their service portfolios, and forming strategic alliances. As the market evolves, intensified competition is expected to drive the market over the estimated period.

Middle East & Africa Healthcare Third-Party Logistics Market Trends

The healthcare third-party logistics market in the Middle East & Africa is growing steadily due to increased pharmaceutical product requirements, healthcare investments, and rising government initiatives to improve healthcare infrastructure. In addition, third-party logistics services are becoming crucial for distributing pharmaceuticals, biologics, vaccines, and medical devices, which play a significant role in temperature-controlled and secure handling. Besides, the market prioritizes the rising adoption of cost-effective technologies like RFID tracking, automated inventory systems, and IoT-enabled cold chain monitoring to enhance visibility, minimize risk, and adhere to regulatory standards.

The UAE healthcare third-party logistics market is rapidly growing, driven by rising demand for advanced medical treatments and an increase in pharmaceutical product consumption. Besides, the government’s strategic initiative to establish the UAE as a regional healthcare and logistics hub is expected to drive market growth. In addition, increased healthcare spending, modernized regulations, and efforts to improve access to specialized therapies have increased the need for efficient, compliant, and scalable supply chain solutions. Moreover, the UAE’s competitive healthcare 3PL market is fueled by key players such as DHL and Aramex, Aetna Inc., Mednet, Nextcare, GlobeMed Ltd., and Sehteq. For instance, in March 2026, Dubai South announced the launch of a new distribution facility by Hellmann Calipar Healthcare Logistics (HCHL) within its Logistics District. The expansion increases Hellmann’s UAE network to five distribution centers, reinforcing its dedicated healthcare logistics capabilities across the Middle East. The new facility addresses rising demand for reliable healthcare supply chains, driven by stricter regulations and the growing need for precise handling and visibility of temperature-sensitive medical products throughout the logistics process.

Key Healthcare Third-Party Logistics Companies Insights

The global healthcare third-party logistics market is experiencing significant growth, with the major market players including Cardinal Health, DHL Group, Agility, SF Express, Kinesis Medical B.V., United Parcel Service of America, Inc., Barrett Distribution, AmerisourceBergen Corporation, DB Schenker, FedEx, KUEHNE + NAGEL, Kerry Logistics Network Ltd., and Freight Logistics Solutions. These firms offer comprehensive services from cell line development to commercial manufacturing, driving innovation and efficiency in biologic drug production. For instance, in March 2025, Barrett Distribution Centers, a recognized leader in third-party logistics specializing in e-commerce and omnichannel fulfillment, introduced the E-commerce Accelerator program. This initiative is created to support fast-growing, early-stage brands in scaling their logistics operations effectively and efficiently.

Key Healthcare Third-Party Logistics Companies

The following key companies have been profiled for this study on the third-party logistics market.

• Cardinal Health
• DHL Group
• Agility
• SF Express
• Kinesis Medical B.V.
• United Parcel Service of America, Inc.
• Barrett Distribution
• AmerisourceBergen Corporation
• DB Schenker
• FedEx
• KUEHNE + NAGEL
• Kerry Logistics Network Ltd.
• Freight Logistics Solutions

Recent Developments

• In November 2025, United Parcel Service of America, Inc. mentioned the completion of the acquisition of Andlauer Healthcare Group, a Canada-based provider of specialized healthcare supply chain solutions, including third-party logistics and temperature-controlled transportation services.  The acquisition will strengthen UPS’s healthcare logistics portfolio and reinforce its focus on expanding specialized global capabilities in the healthcare sector.
• In May 2025, DHL Group announced the strategic expansion of its Life Sciences & Healthcare (LSH) campus in Germany, transforming the facility into a key European pharmaceutical hub. This development is part of DHL Health Logistics’ broader global multibillion-euro investment. The campus now features a fourth state-of-the-art logistics center, bringing the total warehouse space to 100,000 square meters, an area equivalent to over 14 soccer fields. The expanded site will provide capacity for more than 140,000 pallets of pharmaceutical and medical products. Serving a diverse range of international clients in biopharma, specialty pharma, medical technology, and clinical research, the campus employs over 600 skilled professionals dedicated to supporting advanced healthcare logistics.
• In March 2025, DHL Group and Cryoport, Inc. announced that DHL had fully acquired CRYOPDP, a prominent specialty courier specializing in clinical trials, biopharmaceuticals, and cell and gene therapies. In addition, the two companies revealed a strategic partnership aimed at enhancing their supply chain services for the global life sciences and healthcare industries.

Global Healthcare Third-party Logistics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare third-party logistics market report based on industry, service, supply chain, and region:

• Industry Outlook (Revenue, USD Billion, 2021 – 2033)
  • Biopharmaceutical
    • Vaccines
    • Biosimilars
    • Plasma Derived Products
    • Others
  • Pharmaceutical
  • Medical Device
    • Class I
    • Class II
    • Class III
• Service Outlook (Revenue, USD Billion, 2021 – 2033)
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Other
• Supply Chain Outlook (Revenue, USD Billion, 2021 – 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics
• Regional Outlook (Revenue, USD Billion, 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Delivered Customizations

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Industry
1.2.2. Service
1.2.3. Supply Chain
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Third-Party Logistics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Enhanced efficiency and cost reduction
3.2.1.2. Strengthened competitive advantage
3.2.1.3. Technological advancements in logistics
3.2.1.4. Growing applications of reverse logistics in biopharmaceutical industry
3.2.1.5. Rising demand for cold chain logistics
3.2.2. Market Restraint Analysis
3.2.2.1. Increased risk of data and regulatory breaches
3.2.2.2. Rising operational costs and labor shortages
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Healthcare Third-Party Logistics Market: Industry Estimates & Trend Analysis
4.1. Healthcare Third-Party Logistics Market, By Industry: Segment Dashboard
4.2. Healthcare Third-Party Logistics Market, By Industry: Movement Analysis
4.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Industry, 2021 – 2033 (USD Billion)
4.4. Biopharmaceutical
4.4.1. Biopharmaceutical Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.4.2. Vaccines
4.4.2.1. Vaccines Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.4.3. Biosimilars
4.4.3.1. Biosimilars Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.4.4. Plasma Derived Products
4.4.4.1. Plasma Derived Products Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.4.5. Others
4.4.5.1. Others Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.5. Pharmaceutical
4.5.1. Pharmaceutical Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.6. Medical Device
4.6.1. Medical Device Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.6.2. Class I
4.6.2.1. Class I Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.6.3. Class II
4.6.3.1. Class II Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
4.6.4. Class III
4.6.4.1. Class III Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Chapter 5. Healthcare Third-Party Logistics Market: Service Estimates & Trend Analysis
5.1. Healthcare Third-Party Logistics Market, By Service: Segment Dashboard
5.2. Healthcare Third-Party Logistics Market, By Service: Movement Analysis
5.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Service, 2021 – 2033 (USD Billion)
5.4. Transportation
5.4.1. Transportation Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
5.4.2. Air Freight
5.4.2.1. Air Freight Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
5.4.3. Sea Freight
5.4.3.1. Sea Freight Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
5.4.4. Overland
5.4.4.1. Overland Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
5.5. Warehousing and Storage
5.5.1. Warehousing and Storage Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
5.6. Other
5.6.1. Other Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Chapter 6. Healthcare Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis
6.1. Healthcare Third-Party Logistics Market, By Supply Chain: Segment Dashboard
6.2. Healthcare Third-Party Logistics Market, By Supply Chain: Movement Analysis
6.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Supply Chain, 2021 – 2033 (USD Billion)
6.4. Cold Chain Logistics
6.4.1. Cold Chain Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
6.5. Non-Cold Chain Logistics
6.5.1. Non-Cold Chain Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Chapter 7. Healthcare Third-Party Logistics Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2025 & 2033
7.3. North America
7.3.1. North America Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.3.2. U.S
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4. Europe
7.4.1. Europe Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Australia Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Thailand Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. South Korea Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.6. Latin America
7.6.1. Latin America Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7. MEA
7.7.1. MEA Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.3. UAE
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. UAE Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.4. Saudi Arabia
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.6. Qatar
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Qatar Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
7.7.7. Oman
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Oman Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Key Participant Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
8.3. Company Profiles
8.3.1. Cardinal Health
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. DHL Group
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Agility
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. SF Express
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Kinesis Medical B.V.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. United Parcel Service of America, Inc.
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Barrett Distribution
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. AmerisourceBergen Corporation
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. DB Schenker
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. FedEx
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. KUEHNE + NAGEL
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Kerry Logistics Network Ltd.
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Freight Logistics Solutions
8.3.13.1. Company Overview
8.3.13.2. Financial Performance
8.3.13.3. Service Benchmarking
8.3.13.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 4 Global Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 5 Global Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 6 North America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 – 2033 (USD Billion)
Table 7 North America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 8 North America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 9 North America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 10 U.S. Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 11 U.S. Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 12 U.S. Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 13 Canada Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 14 Canada Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 15 Canada Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 16 Canada Healthcare Third-Party Logistics Market Estimates and Forecasts, by End-Use, 2021 – 2033 (USD Billion)
Table 17 Mexico Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 18 Mexico Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 19 Mexico Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 20 Mexico Healthcare Third-Party Logistics Market Estimates and Forecasts, by End-Use, 2021 – 2033 (USD Billion)
Table 21 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 – 2033 (USD Billion)
Table 22 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 23 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 24 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 25 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, by End-Use, 2021 – 2033 (USD Billion)
Table 26 UK Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 27 UK Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 28 UK Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 29 UK Healthcare Third-Party Logistics Market Estimates and Forecasts, by End-Use, 2021 – 2033 (USD Billion)
Table 30 Germany Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 31 Germany Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 32 Germany Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 33 France Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 34 France Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 35 France Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 36 Italy Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 37 Italy Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 38 Italy Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 39 Spain Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 40 Spain Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 41 Spain Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 42 Denmark Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 43 Denmark Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 44 Denmark Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 45 Sweden Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 46 Sweden Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 47 Sweden Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 48 Norway Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 49 Norway Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 50 Norway Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 51 Asia Pacific Healthcare Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 – 2033 (USD Billion)
Table 52 Asia Pacific Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 53 Asia Pacific Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 54 Asia Pacific Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 55 Japan Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 56 Japan Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 57 Japan Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 58 China Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 59 China Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 60 China Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 61 India Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 62 India Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 63 India Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 64 Australia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 65 Australia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 66 Australia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 67 Thailand Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 68 Thailand Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 69 Thailand Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 70 South Korea Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 71 South Korea Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 72 South Korea Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 73 Latin America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 – 2033 (USD Billion)
Table 74 Latin America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 75 Latin America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 76 Latin America Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 77 Brazil Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 78 Brazil Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 79 Brazil Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 80 Argentina Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 81 Argentina Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 82 Argentina Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 83 Middle East & Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 – 2033 (USD Billion)
Table 84 Middle East & Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 85 Middle East & Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 86 Middle East & Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 87 South Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 88 South Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 89 South Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 90 Saudi Arabia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 91 Saudi Arabia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 92 Saudi Arabia Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 93 UAE Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 94 UAE Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 95 UAE Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 96 Kuwait Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 97 Kuwait Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 98 Kuwait Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 99 Oman Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 100 Oman Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 101 Oman Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)
Table 102 Qatar Healthcare Third-Party Logistics Market Estimates and Forecasts, by Industry, 2021 – 2033 (USD Billion)
Table 103 Qatar Healthcare Third-Party Logistics Market Estimates and Forecasts, by Service, 2021 – 2033 (USD Billion)
Table 104 Qatar Healthcare Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 – 2033 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2025 (USD Billion)
Fig. 15 Ancillary market outlook, 2025 (USD Billion)
Fig. 16 Large Molecule Drug Substance Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Healthcare Third-Party Logistics Market: Industry outlook and key takeaways
Fig. 20 Healthcare Third-Party Logistics Market: Industry movement analysis
Fig. 21 Biopharmaceutical Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 22 Vaccines Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 23 Biosimilars Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 24 Plasma Derived Products Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 25 Others Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 26 Pharmaceutical Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 27 Medical Device Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 28 Class I Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 29 Class II Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 30 Class III Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 31 Healthcare Third-Party Logistics Market: Service outlook and key takeaways
Fig. 32 Healthcare Third-Party Logistics Market: Service movement analysis
Fig. 33 Transportation Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 34 Air Freight Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 35 Sea Freight Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 36 Overland Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 37 Warehousing and Storage Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 38 Other Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 39 Healthcare Third-Party Logistics Market: Supply Chain outlook and key takeaways
Fig. 40 Healthcare Third-Party Logistics Market: Supply Chain movement analysis
Fig. 41 Cold Chain Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 42 Non-cold Chain Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 43 Regional Marketplace: Key Takeaways
Fig. 44 North America Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 45 Key country dynamics
Fig. 46 U.S. Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 47 Key country dynamics
Fig. 48 Canada Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 49 Key country dynamics
Fig. 50 Mexico Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 51 Europe Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 52 Key country dynamics
Fig. 53 UK Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 54 Key country dynamics
Fig. 55 Germany Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 56 Key country dynamics
Fig. 57 France Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 58 Key country dynamics
Fig. 59 Italy Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 60 Key country dynamics
Fig. 61 Spain Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 62 Key country dynamics
Fig. 63 Denmark Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 64 Key country dynamics
Fig. 65 Sweden Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 66 Key country dynamics
Fig. 67 Norway Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 68 Asia Pacific Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 69 Key country dynamics
Fig. 70 Japan Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 71 Key country dynamics
Fig. 72 China Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 73 Key country dynamics
Fig. 74 India Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 75 Key country dynamics
Fig. 76 Australia Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 77 Key country dynamics
Fig. 78 Thailand Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 79 Key country dynamics
Fig. 80 South Korea Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 81 Latin America Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 82 Key country dynamics
Fig. 83 Brazil Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 84 Key country dynamics
Fig. 85 Argentina Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 86 MEA Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 87 Key country dynamics
Fig. 88 South Africa Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 89 Key country dynamics
Fig. 90 UAE Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 91 Key country dynamics
Fig. 92 Saudi Arabia Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 93 Key country dynamics
Fig. 94 Kuwait Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 95 Key country dynamics
Fig. 96 Qatar Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 97 Key country dynamics
Fig. 98 Oman Healthcare Third-Party Logistics Market Estimates and Forecasts, 2021 – 2033 (USD Billion)
Fig. 99 Key company categorization
Fig. 100 Service heat map analysis
Fig. 101 Strategic framework

---

---